The gene-editing technique known as CRISPR has accelerated biological and medical research in the last decade by allowing scientists to repair the DNA of human cells almost as simply as using a pair of scissors.
The biotech expects that, by keeping its focus on more advanced projects and clinical programs, it could save on average $40 million to $50 million annually for the next several years
After 14 years, Agios is looking for a partner to tango with, but tough changes lie ahead aarmstrong Mon, 05/16/2022 – 15:49
ObvioHealth’s new AI-based tools aim to take subjectivity out of pediatric trials aarmstrong Mon, 05/16/2022 – 12:25
Avanos Medical faces Class I recall for feeding tube system linked to 23 deaths since 2015 apark Mon, 05/16/2022 – 11:36